Verde Bio Holdings Inc

PINK:APHD USA Shell Companies
Market Cap
$1.80K
Market Cap Rank
#49890 Global
#15237 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$20.10
About

Apogee 21 Holdings, Inc. doing business as A21 Wine & Spirits, produces and markets craft spirits and wine. The company owns Monkey in Paradise Vodka, Andale Tequila, and Blue Nectar Tequila brands. The company also has the sales agency for Zunte Mezcal, and Finca Ferrer Wines from Argentina. The company was formerly known as 30DC, Inc. and changed its name to Apogee 21 Holdings, Inc. in August 2… Read more

Verde Bio Holdings Inc (APHD) - Net Assets

Latest net assets as of January 2024: $285.77K USD

Based on the latest financial reports, Verde Bio Holdings Inc (APHD) has net assets worth $285.77K USD as of January 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.88 Million) and total liabilities ($1.60 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $285.77K
% of Total Assets 15.18%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change 224.11%
Growth Volatility 401530.65

Verde Bio Holdings Inc - Net Assets Trend (2001–2023)

This chart illustrates how Verde Bio Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Verde Bio Holdings Inc (2001–2023)

The table below shows the annual net assets of Verde Bio Holdings Inc from 2001 to 2023.

Year Net Assets Change
2023-04-30 $2.32 Million +265.13%
2022-04-30 $-1.41 Million -3.43%
2021-04-30 $-1.36 Million +56.65%
2020-04-30 $-3.13 Million -56.22%
2019-04-30 $-2.01 Million -31.64%
2018-04-30 $-1.52 Million +11.32%
2017-04-30 $-1.72 Million -261.23%
2016-04-30 $-475.88K +45.01%
2015-04-30 $-865.46K -220.85%
2014-04-30 $716.13K -0.70%
2013-04-30 $721.21K +536.38%
2012-04-30 $-165.27K -193.25%
2011-04-30 $-56.36K +87.27%
2010-04-30 $-442.88K -203.10%
2009-04-30 $429.57K +310.08%
2008-04-30 $104.75K +243.64%
2007-04-30 $-72.93K -133.84%
2006-04-30 $215.49K +1077370.00%
2002-04-30 $20.00 +114.93%
2001-04-30 $-134.00 --

Equity Component Analysis

This analysis shows how different components contribute to Verde Bio Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1603106800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (April 2023)

Component Amount Percentage
Common Stock $1.54 Million 1410.84%
Other Comprehensive Income $-1.00 0.00%
Other Components $14.60 Million 13348.24%
Total Equity $109.37K 100.00%

Verde Bio Holdings Inc Competitors by Market Cap

The table below lists competitors of Verde Bio Holdings Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Verde Bio Holdings Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from -1,405,629 to 109,373, a change of 1,515,002.
  • Dividend payments of 89,064 reduced retained earnings.
  • Other comprehensive income increased equity by 424.
  • Other factors increased equity by 1,603,642.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income $0.00 -0.0%
Dividends Paid $89.06K -81.43%
Other Comprehensive Income $424.00 +0.39%
Other Changes $1.60 Million +1466.21%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Verde Bio Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.00x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2001-04-30 $0.00 $0.00 x
2002-04-30 $0.00 $0.00 x
2003-04-30 $0.00 $0.00 x
2004-04-30 $0.00 $0.00 x
2005-04-30 $-0.03 $0.00 x
2006-04-30 $9.72 $0.00 x
2007-04-30 $-3.17 $0.00 x
2008-04-30 $4.29 $0.00 x
2009-04-30 $16.34 $0.00 x
2010-04-30 $-16.95 $0.00 x
2011-04-30 $-0.20 $0.00 x
2012-04-30 $-0.55 $0.00 x
2013-04-30 $2.18 $0.00 x
2014-04-30 $2.12 $0.00 x
2015-04-30 $-2.82 $0.00 x
2016-04-30 $-0.04 $0.00 x
2017-04-30 $-0.03 $0.00 x
2018-04-30 $-0.10 $0.00 x
2019-04-30 $-13.64 $0.00 x
2020-04-30 $-2.04 $0.00 x
2021-04-30 $-0.94 $0.00 x
2022-04-30 $-0.97 $0.00 x
2023-04-30 $0.08 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Verde Bio Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-626.74%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2001 0.00% -663.50% 2.70x 0.00x $-1.31K
2002 -13410.00% -924.83% 14.50x 1.00x $-1.34K
2003 0.00% 0.00% 0.00x 0.00x $-1.52K
2004 0.00% 0.00% 0.00x 0.00x $2.00
2005 0.00% 0.00% 0.00x 0.00x $-1.70K
2006 -382.12% -30817.78% 0.01x 2.13x $-845.00K
2007 0.00% -1782.20% 0.08x 0.00x $-340.63K
2008 30.37% 31.81% 0.22x 4.36x $21.34K
2009 21.79% 6658.04% 0.00x 2.36x $50.65K
2010 0.00% -32888.94% 0.01x 0.00x $-883.18K
2011 0.00% -76.06% 1.07x 0.00x $-1.43 Million
2012 0.00% 1.10% 1.03x 0.00x $48.73K
2013 -56.52% -20.66% 0.69x 3.97x $-479.76K
2014 8.23% 2.11% 1.06x 3.69x $-12.69K
2015 0.00% -216.66% 0.51x 0.00x $-1.51 Million
2016 0.00% -16072.23% 0.68x 0.00x $-97.71K
2017 0.00% -4918.37% 0.88x 0.00x $-2.30 Million
2018 0.00% -4287.52% 1.76x 0.00x $-1.64 Million
2019 0.00% 0.00% 0.00x 0.00x $-686.74K
2020 0.00% 0.00% 0.00x 0.00x $-1.49 Million
2021 0.00% 0.00% 0.00x 0.00x $1.13 Million
2022 0.00% 0.00% 0.00x 0.00x $29.34K

Industry Comparison

This section compares Verde Bio Holdings Inc's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $-56,363,212
  • Average return on equity (ROE) among peers: -7.18%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Verde Bio Holdings Inc (APHD) $285.77K 0.00% 5.59x $143.77
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $-22.04K 0.00% 0.00x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $5.32 Million -71.85% 3.84x $15.42 Million
ABV Consulting Inc (ABVN) $-185.37K 0.00% 0.00x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-181.19K 0.00% 0.00x $14.73K
ACRO Biomedical Co Ltd (ACBM) $-14.79K 0.00% 0.00x $30.04K
Huaizhong Health Group Inc (ADAD) $-1.02K 0.00% 0.00x $3.15K